본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Long-Term Cancer Incidence Trends in Korea (2001-2020): An Age-Period-Cohort and Joinpoint Analysis with a Focus on Younger Cohorts Chung Jinsoo
(Immuno-oncology Branch)

Lee Hyung Ho
(Center for Prostate Cancer)
. Long-Term Cancer Incidence Trends in Korea (2001-2020): An Age-Period-Cohort and Joinpoint Analysis with a Focus on Younger Cohorts. MEDICINA-LITHUANIA. 2025-12-08; 2025; 61(12):2179~. IF 2.4 (2024)
Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer Shim Jae Gal
(Cancer Metastasis Branch)

Sung Jee Young
(Cancer Metastasis Branch)
. Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer. JOURNAL OF TRANSLATIONAL MEDICINE. 2025-12-05; 2025; 23(1):1380~. IF 7.5 (2024)
Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region
()

Kim Ho Jin
(Immuno-oncology Branch)
. Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region. MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2025-12-04; 2025; 105:106897~. IF 2.9 (2024)
Functional profiling of the oral microbiome reveals microbial and oncogenic signatures in never-smoking female patients with oral squamous cell carcinoma Choi Sung Weon
(Rare & Pediatric Cancer Branch)

Kim Sung Min
(Branch of Oral Maxillofacial Surgery)
. Functional profiling of the oral microbiome reveals microbial and oncogenic signatures in never-smoking female patients with oral squamous cell carcinoma. JOURNAL OF ORAL MICROBIOLOGY. 2025-12-04; 2025; 17(1):2594842~. IF 5.5 (2024)
Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome-Mediated Suppression by Quercetin Ryu Jun sun
(Department of Otorhinolaryngology)


()
. Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome-Mediated Suppression by Quercetin. MOLECULAR CARCINOGENESIS. 2025-12-03; 2025; :~. IF 3.2 (2024)
Evaluation of false positive and false negative errors in targeted next generation sequencing Hong Kyeong Man
(Cancer Molecular Biology Branch)

Youngbeen Moon
(Bioinformatics Analysis Team)
. Evaluation of false positive and false negative errors in targeted next generation sequencing. GENOME BIOLOGY. 2025-12-01; 2025; 26(1):409~. IF 9.4 (2024)
K-LARS trial: protocol for a multicentre randomised controlled trial evaluating a knowledge-enhanced digital intervention to prevent low anterior resection syndrome in Korea Sohn Dae Kyung
(Medical Engineering Branch)


()
. K-LARS trial: protocol for a multicentre randomised controlled trial evaluating a knowledge-enhanced digital intervention to prevent low anterior resection syndrome in Korea. BMJ OPEN. 2025-11-29; 2025; 15(11):e107819~. IF 2.3 (2024)
Development of a real-time tongue motion monitoring system for managing swallowing-induced motion in neck cancer radiation therapy Shin Dong ho
(Department of Radiation oncology)


()
. Development of a real-time tongue motion monitoring system for managing swallowing-induced motion in neck cancer radiation therapy. MEDICAL PHYSICS. 2025-11-27; 2025; 52(12):e70137~. IF 3.2 (2024)
Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial Han Ji-Youn
(Anticancer Resistance Branch )

Ahn Beung Chul
(Targeted Therapy Branch)
. Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial. JAMA ONCOLOGY. 2025-11-26; 2025; 12(1):84~89. IF 20.1 (2024)
Comparable long-term survival and biliary outcomes in ABO-incompatible and compatible living donor liver transplantation Kim Seoung Hoon
(Organ Transplantation Center)

Kim Seoung Hoon
(Organ Transplantation Center)
. Comparable long-term survival and biliary outcomes in ABO-incompatible and compatible living donor liver transplantation. INTERNATIONAL JOURNAL OF SURGERY. 2025-11-25; 2025; :~. IF 10.3 (2024)
First page Prev paging 1 2 3 4 5 6 7 8 9 10 next paging last page